Industry

Walgreens invests in training to equip pharmacists with expert knowledge to address the specific challenges of this chronic, complex condition DEERFIELD, Ill.–(BUSINESS WIRE)–During Diabetes Awareness Month, Walgreens is teaming up with the company’s Health Corners, Village Medical at Walgreens, and third-party clinics to offer complimentary diabetes services, including education focused on management and prevention and … [Read more…]

Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company’s Cardea SOLO™ ECG System BELLEVUE, Wash.–(BUSINESS WIRE)–#ECGscreening—Cardiac Insight, Inc., creators of Cardea SOLO™ prescription cardiac sensors and automated electrocardiography (ECG) Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving … [Read more…]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, Inc. (Asher Bio), a biotechnology company focused on developing therapies to precisely engage specific immune cells to fight cancer, chronic viral infection and autoimmune disease, today announced new preclinical data demonstrating proof-of-concept for AB359 as a novel immunotherapy approach for chronic HBV. AB359 is Asher Bio’s CD8-targeted interleukin-2 (IL-2) … [Read more…]

– Precise injection technique and comprehensive patient assessment can lead to optimized aesthetic outcomes when treating frown lines – NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial-stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the publication of two peer-reviewed articles in the Aesthetic Surgery Journal, the official journal of The … [Read more…]

‒ Q3 2022 Net Revenue of $546 million; GAAP Net Loss of $3 million; Diluted Loss per Share of $(0.02) ‒ ‒ Adjusted EBITDA (1) of $126 million; Adjusted Diluted EPS (1) of $0.14 ‒ ‒ Maintaining 2022 Full Year Outlook ‒ BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced its … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global bronchodilators market size reached US$ 33.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 45.9 Billion by 2027, exhibiting a CAGR of 5.23% during 2021-2027. Companies Mentioned … [Read more…]

New experience delivers end-to-end support for employees and reduces administrative burden for employers SANTA MONICA, Calif.–(BUSINESS WIRE)–Headspace Health, the provider of the world’s most accessible, comprehensive digital mental health platform, today announced a new, unified product experience, bringing together Headspace’s world-class meditation and mindfulness offering with Ginger’s on-demand coaching, therapy and psychiatry services. The new … [Read more…]

LONDON–(BUSINESS WIRE)–Future Planet Capital (“FPC”), the international venture capital and impact investor, is pleased to announce its participation in Edinburgh-based food & ag tech company Roslin Technologies’s latest £11m funding round, helping to fuel the company’s next wave of growth in its mission to become the leading provider of animal cell lines to the emerging … [Read more…]

OXFORD, England–(BUSINESS WIRE)–Beckley Psytech Limited, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, today announces that Cosmo Feilding Mellen, Chief Executive Officer, Steve Wooding, Chief Scientific Officer and Michael Norris, Chief Financial Officer, will attend the Jefferies London Healthcare Conference, being held in London from 15th … [Read more…]

Innate will share preliminary results of the cohort evaluating lacutamab in Sezary syndrome patients post-mogamulizumab from the ongoing TELLOMAK Phase 2 trial Chief Scientific Officer, Eric Vivier, DVM, PhD, to give an oral presentation on multispecific antibodies platform: ANKETTM Partner Sanofi will display two posters on SAR’579/IPH6101 and SAR’514/IPH6401 MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma … [Read more…]